Cambridge Nutritional Sciences plc
CNSL.L · LSE
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Revenue | £8,330 | £9,774 | £7,546 | £8,539 |
| % Growth | -14.8% | 29.5% | -11.6% | – |
| Cost of Goods Sold | £3,325 | £3,728 | £4,373 | £3,790 |
| Gross Profit | £5,005 | £6,046 | £3,173 | £4,749 |
| % Margin | 60.1% | 61.9% | 42% | 55.6% |
| R&D Expenses | £433 | £343 | £274 | £343 |
| G&A Expenses | £0 | £5,287 | £4,755 | £4,438 |
| SG&A Expenses | £5,276 | £6,665 | £6,285 | £5,694 |
| Sales & Mktg Exp. | £0 | £1,378 | £1,530 | £1,256 |
| Other Operating Expenses | -£64 | -£427 | -£607 | -£706 |
| Operating Expenses | £5,645 | £6,581 | £5,952 | £5,331 |
| Operating Income | -£640 | -£535 | -£2,779 | -£582 |
| % Margin | -7.7% | -5.5% | -36.8% | -6.8% |
| Other Income/Exp. Net | £2,206 | -£210 | -£473 | -£358 |
| Pre-Tax Income | £1,566 | -£745 | -£3,252 | -£950 |
| Tax Expense | £0 | -£417 | -£80 | £459 |
| Net Income | £1,566 | -£328 | -£3,860 | -£11,333 |
| % Margin | 18.8% | -3.4% | -51.2% | -132.7% |
| EPS | 0.007 | -0.001 | -0.017 | -0.062 |
| % Growth | 571.4% | 91.6% | 73.1% | – |
| EPS Diluted | 0.007 | -0.001 | -0.017 | -0.062 |
| Weighted Avg Shares Out | 238,271 | 237,727 | 231,264 | 182,638 |
| Weighted Avg Shares Out Dil | 238,271 | 238,097 | 231,264 | 182,638 |
| Supplemental Information | – | – | – | – |
| Interest Income | £147 | £50 | £0 | £0 |
| Interest Expense | £17 | £22 | £13 | £21 |
| Depreciation & Amortization | £615 | £650 | £591 | £547 |
| EBITDA | £2,198 | -£73 | -£2,648 | -£382 |
| % Margin | 26.4% | -0.7% | -35.1% | -4.5% |